Smith EF and Lefer AM |
Stabilization of cardiac lysosomal and cellular membranes in protection of ischemic myocardium due to coronary occlusion:efficacy of the nonsteroidal anti-inflammatory agent, naproxen. |
1981 |
Am. Heart J. |
pmid:7211667
|
Takase B et al. |
Effects of bepridil on silent myocardial ischemia and eicosanoid metabolism in chronic stable angina pectoris after healing of myocardial infarction. |
1994 |
Am. J. Cardiol. |
pmid:8198031
|
Hanet C et al. |
Myocardial protection by intracoronary nicardipine administration during percutaneous transluminal coronary angioplasty. |
1987 |
Am. J. Cardiol. |
pmid:2953226
|
Yasu T et al. |
Effects of aspirin DL-lysine on thrombin generation in unstable angina pectoris. |
1993 |
Am. J. Cardiol. |
pmid:8480641
|
Willerson JT et al. |
Potential usefulness of combined thromboxane A2 and serotonin receptor blockade for preventing the conversion from chronic to acute coronary artery disease syndromes. |
1990 |
Am. J. Cardiol. |
pmid:2146868
|
McDaniel HG et al. |
Platelet function abnormalities in response to arachidonic acid in the acute phase of myocardial infarction. |
1983 |
Am. J. Cardiol. |
pmid:6416046
|
Eldar M et al. |
Bradykinin level in the great cardiac vein during balloon angioplasty of the left anterior descending coronary artery. |
1992 |
Am. J. Cardiol. |
pmid:1466338
|
Dabaghi SF et al. |
Effects of low-dose aspirin on in vitro platelet aggregation in the early minutes after ingestion in normal subjects. |
1994 |
Am. J. Cardiol. |
pmid:7942533
|
Graziani F et al. |
Thromboxane production in morbidly obese subjects. |
2011 |
Am. J. Cardiol. |
pmid:21439532
|
Théroux P et al. |
Hemodynamic, platelet and clinical responses to prostacyclin in unstable angina pectoris. |
1990 |
Am. J. Cardiol. |
pmid:2109927
|
Feldman M and Cryer B |
Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution. |
1999 |
Am. J. Cardiol. |
pmid:10468077
|
Willerson JT et al. |
Conversion from chronic to acute coronary artery disease: speculation regarding mechanisms. |
1984 |
Am. J. Cardiol. |
pmid:6391133
|
Hirsh PD et al. |
Effects of provocation on transcardiac thromboxane in patients with coronary artery disease. |
1983 |
Am. J. Cardiol. |
pmid:6829431
|
Walinsky P et al. |
Beneficial effects of ibuprofen in pacing-induced myocardial ischemia. |
1983 |
Am. J. Cardiol. |
pmid:6829434
|
Milani M et al. |
Effects of fluvastatin and pravastatin on lipid profiles and thromboxane production in type IIa hypercholesterolemia. |
1995 |
Am. J. Cardiol. |
pmid:7604798
|
Roy L et al. |
Increased plasma concentrations of prostacyclin metabolite 6-keto-PGF1 alpha in essential hypertension. Influence of therapy with labetalol. |
1983 |
Am. J. Cardiol. |
pmid:6823861
|
Lam JY et al. |
Platelet aggregation, coronary artery disease progression and future coronary events. |
1994 |
Am. J. Cardiol. |
pmid:8109546
|
Timmermans C et al. |
Ridogrel in the setting of percutaneous transluminal coronary angioplasty. |
1991 |
Am. J. Cardiol. |
pmid:1872272
|
Mason PJ et al. |
Plasma, serum, and platelet expression of CD40 ligand in adults with cardiovascular disease. |
2005 |
Am. J. Cardiol. |
pmid:16275179
|
Rehr RB et al. |
Mechanism of nitroglycerin-induced coronary dilatation: lack of relation to intracoronary thromboxane concentrations. |
1984 |
Am. J. Cardiol. |
pmid:6437206
|